# EXECUTIVE SUMMARY: Synthetic Lethality Therapy Ranking (S/P/E Pipeline)

## üéØ Clinical Goal
Establish a deterministic, biologically grounded ranking system for synthetic lethality (SL) therapies (PARP, ATR, WEE1) that prevents clinical "over-calling" while maintaining high sensitivity for validated mechanistic vulnerabilities.

## üìä Key Results

### 1. Clinical Predictive Value (TCGA-OV)
- **Signal**: Retrospective prediction of platinum response (surrogate for HRD).
- **Metric**: **AUROC = 0.70** (n=149).
- **Verdict**: Proven mechanistic signal in real patient outcomes.

### 2. Structural Rigor (100-Case Benchmark)
- **Accuracy**: **92.9% Drug@1** accuracy.
- **Safety**: **0% false-positive rate** on SL-negative cases.
- **Comparison**: Significantly outperformed 90-gene rule base (33.3% FP rate).

### 3. Technical Refinements
- **Functionalized DepMap Grounding**: Lineage-aware dependency scores act as a functional scoring term and "safety net."
- **Confidence Resolver**: Literature component (E) augmented as a tie-breaker using clinical PMIDs (bumps score from e.g., 0.91 to 0.98).
- **S/P Necessity**: Ablation shows system collapse (18.6%) without both Sequence (Evo2) and Pathway components.

## üìÇ Bundle Structure
- `manuscript/`: Nature Medicine draft + Technical master.
- `figures/clinical/`: ROC, Survival, and Waterfall plots from TCGA-OV.
- `results/clinical/`: Detailed clinical validation reports.
- `results/`: Benchmark execution receipts.
- `data/`: 100-case dataset + lineage-aware DepMap grounding JSON.

## üõ†Ô∏è Implementation
The S/P/E logic is implemented in the `oncology-backend-minimal` core services, ensuring that these "mechanistic floors" are functional in the decision support pipeline.
